Dr. Anika Patel, Phd

Quantum Oncology Researcher

Profile

Dr. Anika Patel

PhD in Computational Biology, Massachusetts Institute of Technology (MIT)
Postdoctoral Fellowship, Stanford University, Cancer Systems Biology Lab
BSc in Biomedical Engineering, University of California, Berkeley

Current Role At Neovita

Dr. Patel serves as a Quantum Oncology Researcher at NeoVita Oncology, leading initiatives in applying quantum computing and advanced computational models to cancer research. She focuses on accelerating drug discovery, predictive modeling, and precision oncology strategies.

Expertise & Specialization

• Quantum computing applications in oncology
• Computational modeling of cancer biology
•Precision medicine and drug discovery
•Translational research and data-driven oncology

Memberships & Affiliation

•American Association for Cancer Research (AACR)
•Society for Computational Biology (SCB)
•International Society for Quantum Computing in Medicine

Biography

Dr. Anika Patel earned her PhD in Computational Biology from MIT, followed by a postdoctoral fellowship at Stanford University’s Cancer Systems Biology Lab. She also holds a BSc in Biomedical Engineering from UC Berkeley. At NeoVita Oncology, she applies quantum computing and computational modeling to accelerate drug discovery, improve predictive oncology, and support personalized treatment strategies.

Career highlights & Achievements

Dr. Patel is recognized for pioneering the integration of quantum computing with oncology research, enabling more accurate predictions of drug efficacy and patient-specific treatment responses. She has led multiple high-impact projects in computational oncology, published extensively in peer-reviewed journals, and presented at international conferences. Her work bridges the gap between advanced computational technologies and practical cancer therapies.